THE EFFECT OF A BETA-ADRENERGIC BLOCKING AGENT (NETHALIDE) ON SERUM LIPIDS AND GLUCOSE IN MAN.
D018674:Adrenergic Antagonists; D035843:Biomedical Research; D001786:Blood Glucose; D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease; D004358:Drug Therapy; D005227:Fatty Acids; D005947:Glucose / Q000378:metabolism*; D005989:Glycerides; D006801:Humans; D006973:Hypertension; D008055:Lipids / Q000097:blood*; D008297:Male; D009765:Obesity; D010743:Phospholipids; D005082:Physical Exertion; D012146:Rest; D012507:Sarcoidosis; D013565:Sympatholytics
D018674:Adrenergic Antagonists; D001786:Blood Glucose; D005227:Fatty Acids; D005989:Glycerides; D008055:Lipids; D010743:Phospholipids; D013565:Sympatholytics; D002784:Cholesterol; D005947:Glucose
BLOOD CHOLESTEROL; BLOOD LIPIDS; BLOOD SUGAR; CLINICAL RESEARCH; CORONARY DISEASE; DRUG THERAPY; EXERTION; FATTY ACIDS; GLUCOSE METABOLISM; GLYCERIDES; HYPERTENSION; OBESITY; PHOSPHOLIPIDS; REST; SARCOIDOSIS; SYMPATHOLYTICS